Retinoblastoma secondary prevention: Difference between revisions
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{Sahar}} | {{CMG}}; {{AE}} {{Sahar}} | ||
==Overview== | ==Overview== | ||
Early [[diagnosis]] of [[retinoblastoma]] is necessary to obtain the best outcomes for [[vision]] and eye salvage. In 2018, a group of experts in clinical [[retinoblastoma]] care and [[ophthalmic]] | |||
[[pathology]] and [[genetics]] suggest a risk-stratified schedule for [[ophthalmic]] [[screening]] examinations. Estimated risk of [[retinoblastoma]] development is calculated according to the relativity of individuals to the family member with [[retinoblastoma]]. | |||
==Secondary Prevention== | ==Secondary Prevention== | ||
For more information on retinoblastoma secondary prevention [[Retinoblastoma screening|click here]]. | For more information on retinoblastoma secondary prevention [[Retinoblastoma screening|click here]]. | ||
Revision as of 15:06, 16 May 2019
|
Retinoblastoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Retinoblastoma secondary prevention On the Web |
|
American Roentgen Ray Society Images of Retinoblastoma secondary prevention |
|
Risk calculators and risk factors for Retinoblastoma secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]
Overview
Early diagnosis of retinoblastoma is necessary to obtain the best outcomes for vision and eye salvage. In 2018, a group of experts in clinical retinoblastoma care and ophthalmic pathology and genetics suggest a risk-stratified schedule for ophthalmic screening examinations. Estimated risk of retinoblastoma development is calculated according to the relativity of individuals to the family member with retinoblastoma.
Secondary Prevention
For more information on retinoblastoma secondary prevention click here.
References